About Zevra
Zevra is a company based in Celebration (United States) founded in 2006 by Christal MM Mickle. The company has 59 employees as of December 31, 2024. Zevra has completed 1 acquisition, including Acer Therapeutics. Zevra offers products and services including MIPLYFFA, OLPRUVA, and AZSTARYS. Zevra operates in a competitive market with competitors including Sayre Therapeutics, Supreme Optimization, Ethosh, Techizer and Andira, among others.
- Headquarter Celebration, United States
- Employees 59 as on 31 Dec, 2024
- Founders Christal MM Mickle
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Zevra Therapeutics, Inc.
-
Annual Revenue
$23.61 M (USD)-14.02as on Dec 31, 2024
-
Net Profit
-$105.51 M (USD)-129.13as on Dec 31, 2024
-
EBITDA
-$80.61 M (USD)-65.88as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
59
as on Dec 31, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Zevra
Zevra is a publicly listed company on the NASDAQ with ticker symbol ZVRA in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Zevra
Zevra offers a comprehensive portfolio of products and services, including MIPLYFFA, OLPRUVA, and AZSTARYS.
Treats specific rare diseases through targeted therapy approaches.
Addresses unmet needs in rare metabolic disorders effectively.
Focuses on neurological conditions with innovative treatment methods.
People of Zevra
Unlock access to complete
Funding Insights of Zevra
Detailed funding history for Zevra
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zevra
Zevra has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Acer Therapeutics.
Investment portfolio details for Zevra
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Treatments for ultra-rare diseases like vEDS and MSUD are developed.
|
Locked | Locked | 1991 | Locked |
Complete acquisition details for Zevra
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Zevra
Detailed financials for Zevra
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Zevra Comparisons
Peer comparison for Zevra
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Zevra
Zevra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sayre Therapeutics, Supreme Optimization, Ethosh, Techizer and Andira, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Access to therapies for rare and life-threatening diseases is provided.
|
|
| Locked | Locked | Locked |
Digital marketing services are offered to the life sciences sector.
|
|
| Locked | Locked | Locked |
Provider of digital experience and marketing services to health-tech and life-sciences organizations
|
|
| Locked | Locked | Locked |
Marketing software for pharmacies is provided by Techizer.
|
|
| Locked | Locked | Locked |
Digital pharmacotherapeutic platform for providers
|
Detailed competitors of Zevra
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Zevra
Complete news archive for Zevra
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zevra
Zevra was founded in 2006.
Zevra is headquartered in Celebration, United States. It is registered at Celebration, Florida, United States.
Neil F McFarlane is the current CEO of Zevra.
As of Dec 31, 2024, the latest employee count at Zevra is 59.
Annual revenue of Zevra is $23.61M as on Dec 31, 2024.
Zevra was established in 2006 in Celebration, United States, as a provider of marketing services focused on the biopharma sector. Operations center on supporting pharmaceutical and biotechnology firms through targeted marketing strategies. Services include promotional campaigns, market analysis, and communication tools tailored to industry needs. The company is led by co-founder Christal MM Mickle and CEO Neil F McFarlane, with activities conducted primarily in the U.S. market.
Zevra's top competitors include Sayre Therapeutics, Ethosh and CMI Media Group.
Zevra offers MIPLYFFA, OLPRUVA, and AZSTARYS.
Yes, Zevra is publicly traded on NASDAQ under the ticker symbol ZVRA.
Zevra has made 1 acquisition, including Acer Therapeutics.
The ticker symbol of Zevra is ZVRA on NASDAQ.